Welcome to LookChem.com Sign In|Join Free

CAS

  • or

91281-33-3

Post Buying Request

91281-33-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91281-33-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91281-33-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,2,8 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 91281-33:
(7*9)+(6*1)+(5*2)+(4*8)+(3*1)+(2*3)+(1*3)=123
123 % 10 = 3
So 91281-33-3 is a valid CAS Registry Number.

91281-33-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Phenol, 4-[(2-aminoethyl)thio]-, hydrochloride (1:1)

1.2 Other means of identification

Product number -
Other names Phenol, 4-[(2-aminoethyl)thio]-, hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91281-33-3 SDS

91281-33-3Relevant articles and documents

Biomimetic Oxidation of the Antimelanoma Agent 4-S-Cysteaminylphenol and Related Catechol Thioethers: Isolation and Reaction Behaviour of Novel Dihydrobenzothiazinequinones

Mascagna, Donatella,Costantini, Claudio,d'Ischia, Marco,Prota, Giuseppe

, p. 8757 - 8764 (1994)

Enzymatic and chemical oxidation of 4-S-cysteaminylphenol (1) and 4-S-cysteaminylcatechol (2) leads to the formation of the hitherto unknown dihydrobenzothiazine-6,7-quinone 4 via intramolecular cyclisation of the o-quinone 6.Oxidation of 4-S-cysteinylcat

Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma

Jordan, Allan M.,Khan, Tariq H.,Malkin, Hugh,Osborn, Helen M.I.,Photiou, Andrew,Riley, Patrick A.

, p. 1549 - 1558 (2007/10/03)

Evaluation of second generation prodrugs for MDEPT, by oximetry, has highlighted structural properties that are advantageous and disadvantageous for efficient oxidation using mushroom tyrosinase. In particular, a sterically undemanding prodrug bis-(2-chlo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91281-33-3